We are analyzing https://link.springer.com/article/10.1007/s11065-007-9025-y.

Title:
Use of Functional Magnetic Resonance Imaging in the Early Identification of Alzheimer's Disease | Neuropsychology Review
Description:
Neuropsychology Review - A growing body of evidence suggests that a preclinical phase of Alzheimer
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

google, scholar, article, pubmed, disease, alzheimers, cas, journal, brain, neurology, cognitive, functional, memory, risk, aging, bondi, fmri, mild, alzheimer, impairment, neuropsychological, apoe, imaging, preclinical, cerebral, neuropsychology, salmon, activation, usa, hippocampal, magnetic, resonance, normal, psychiatry, proceedings, early, dementia, international, society, apolipoprotein, academy, study, neuroimaging, evidence, adults, human, sciences, neuroscience, neuroimage, national,

Topics {✒️}

arterial spin labeling month download article/chapter magnetic resonance imaging tract-based spatial statistics verbal paired-associate learning multi-subject diffusion data activated human cortex characterizing function-structure relationships enhanced brain activity [18f]fdg pet study human brain mapping cerebral blood flow functional mr imaging apoe ε4 allele diffusion tensor imaging full article pdf functional brain imaging privacy choices/manage cookies human memory system magnetic resonance brain-imaging measurements human cerebral microvessels magnetoencephalography differences altered brain activation human visual system default mode hypothesis medial temporal lobe increased brain activation memory-impaired individuals mild cognitive impairment mild cognitive decline increased hippocampal activation predicts memory performance functional mri activation age-related decline california san diego semantic memory impairment reduced hippocampal activation �mini-mental state cross-level unification acta neurologica scandinavica perfusion imaging rate regional atrophy fronto-temporal pathways functional brain abnormalities memory systems impairment focal activation hemodynamics mri diffusion indices cerebrovascular risk factors nature reviews neuroscience

Questions {❓}

Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD?
Biomarkers in the diagnosis of Alzheimer's disease: Are we ready?
Cognitive performance in relatives of patients with probable Alzheimer's disease: An age at onset effect?
Heterogeneity in verbal memory: A marker of preclinical Alzheimer's disease?
Mild cognitive impairment: Where are we?
Military population: Evidence of a neuropsychological compensatory mechanism?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Use of Functional Magnetic Resonance Imaging in the Early Identification of Alzheimer's Disease
         description:A growing body of evidence suggests that a preclinical phase of Alzheimer's disease (AD) exists several years or more prior to the overt manifestation of clinical symptoms and is characterized by subtle neuropsychological and brain changes. Identification of individuals prior to the development of significant clinical symptoms is imperative in order to have the greatest treatment impact by maintaining cognitive abilities and preserving quality of life. Functional magnetic resonance imaging (fMRI) offers considerable promise as a non-invasive tool for detecting early functional brain changes in asymptomatic adults. In fact, evidence to date indicates that functional brain decline precedes structural decline in preclinical samples. Therefore, fMRI may offer the unique ability to capture the dynamic state of change in the degenerating brain. This review examines the clinical utility of blood oxygen level dependent (BOLD) fMRI in those at risk for AD as well as in early AD. We provide an overview of fMRI findings in at-risk groups by virtue of genetic susceptibility or mild cognitive decline followed by an appraisal of the methodological issues concerning the diagnostic usefulness of fMRI in early AD. We conclude with a discussion of future directions and propose that BOLD-fMRI in combination with cerebral blood flow or diffusion techniques will provide a more complete accounting of the neurovascular changes that occur in preclinical AD and thus improve our ability to reliably detect early brain changes prior to disease onset.
         datePublished:2007-05-03T00:00:00Z
         dateModified:2007-05-03T00:00:00Z
         pageStart:127
         pageEnd:143
         sameAs:https://doi.org/10.1007/s11065-007-9025-y
         keywords:
            BOLD-fMRI
            Preclinical Alzheimer's disease
            APOE ε4
            Mild cognitive impairment
            Arterial spin labeling
            Cerebral blood perfusion
            Neurosciences
            Neuropsychology
            Neurology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11065-007-9025-y/MediaObjects/11065_2007_9025_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11065-007-9025-y/MediaObjects/11065_2007_9025_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11065-007-9025-y/MediaObjects/11065_2007_9025_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11065-007-9025-y/MediaObjects/11065_2007_9025_Fig4_HTML.gif
         isPartOf:
            name:Neuropsychology Review
            issn:
               1573-6660
               1040-7308
            volumeNumber:17
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Christina E. Wierenga
               affiliation:
                     name:University of California San Diego
                     address:
                        name:Department of Psychiatry, University of California San Diego, La Jolla, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mark W. Bondi
               affiliation:
                     name:University of California San Diego
                     address:
                        name:Department of Psychiatry, University of California San Diego, La Jolla, USA
                        type:PostalAddress
                     type:Organization
                     name:VA San Diego Healthcare System
                     address:
                        name:Psychology Service, VA San Diego Healthcare System, La Jolla, USA
                        type:PostalAddress
                     type:Organization
                     name:VA San Diego Healthcare System (116B)
                     address:
                        name:VA San Diego Healthcare System (116B), San Diego, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Use of Functional Magnetic Resonance Imaging in the Early Identification of Alzheimer's Disease
      description:A growing body of evidence suggests that a preclinical phase of Alzheimer's disease (AD) exists several years or more prior to the overt manifestation of clinical symptoms and is characterized by subtle neuropsychological and brain changes. Identification of individuals prior to the development of significant clinical symptoms is imperative in order to have the greatest treatment impact by maintaining cognitive abilities and preserving quality of life. Functional magnetic resonance imaging (fMRI) offers considerable promise as a non-invasive tool for detecting early functional brain changes in asymptomatic adults. In fact, evidence to date indicates that functional brain decline precedes structural decline in preclinical samples. Therefore, fMRI may offer the unique ability to capture the dynamic state of change in the degenerating brain. This review examines the clinical utility of blood oxygen level dependent (BOLD) fMRI in those at risk for AD as well as in early AD. We provide an overview of fMRI findings in at-risk groups by virtue of genetic susceptibility or mild cognitive decline followed by an appraisal of the methodological issues concerning the diagnostic usefulness of fMRI in early AD. We conclude with a discussion of future directions and propose that BOLD-fMRI in combination with cerebral blood flow or diffusion techniques will provide a more complete accounting of the neurovascular changes that occur in preclinical AD and thus improve our ability to reliably detect early brain changes prior to disease onset.
      datePublished:2007-05-03T00:00:00Z
      dateModified:2007-05-03T00:00:00Z
      pageStart:127
      pageEnd:143
      sameAs:https://doi.org/10.1007/s11065-007-9025-y
      keywords:
         BOLD-fMRI
         Preclinical Alzheimer's disease
         APOE ε4
         Mild cognitive impairment
         Arterial spin labeling
         Cerebral blood perfusion
         Neurosciences
         Neuropsychology
         Neurology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11065-007-9025-y/MediaObjects/11065_2007_9025_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11065-007-9025-y/MediaObjects/11065_2007_9025_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11065-007-9025-y/MediaObjects/11065_2007_9025_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11065-007-9025-y/MediaObjects/11065_2007_9025_Fig4_HTML.gif
      isPartOf:
         name:Neuropsychology Review
         issn:
            1573-6660
            1040-7308
         volumeNumber:17
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Christina E. Wierenga
            affiliation:
                  name:University of California San Diego
                  address:
                     name:Department of Psychiatry, University of California San Diego, La Jolla, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mark W. Bondi
            affiliation:
                  name:University of California San Diego
                  address:
                     name:Department of Psychiatry, University of California San Diego, La Jolla, USA
                     type:PostalAddress
                  type:Organization
                  name:VA San Diego Healthcare System
                  address:
                     name:Psychology Service, VA San Diego Healthcare System, La Jolla, USA
                     type:PostalAddress
                  type:Organization
                  name:VA San Diego Healthcare System (116B)
                  address:
                     name:VA San Diego Healthcare System (116B), San Diego, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Neuropsychology Review
      issn:
         1573-6660
         1040-7308
      volumeNumber:17
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of California San Diego
      address:
         name:Department of Psychiatry, University of California San Diego, La Jolla, USA
         type:PostalAddress
      name:University of California San Diego
      address:
         name:Department of Psychiatry, University of California San Diego, La Jolla, USA
         type:PostalAddress
      name:VA San Diego Healthcare System
      address:
         name:Psychology Service, VA San Diego Healthcare System, La Jolla, USA
         type:PostalAddress
      name:VA San Diego Healthcare System (116B)
      address:
         name:VA San Diego Healthcare System (116B), San Diego, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Christina E. Wierenga
      affiliation:
            name:University of California San Diego
            address:
               name:Department of Psychiatry, University of California San Diego, La Jolla, USA
               type:PostalAddress
            type:Organization
      name:Mark W. Bondi
      affiliation:
            name:University of California San Diego
            address:
               name:Department of Psychiatry, University of California San Diego, La Jolla, USA
               type:PostalAddress
            type:Organization
            name:VA San Diego Healthcare System
            address:
               name:Psychology Service, VA San Diego Healthcare System, La Jolla, USA
               type:PostalAddress
            type:Organization
            name:VA San Diego Healthcare System (116B)
            address:
               name:VA San Diego Healthcare System (116B), San Diego, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Psychiatry, University of California San Diego, La Jolla, USA
      name:Department of Psychiatry, University of California San Diego, La Jolla, USA
      name:Psychology Service, VA San Diego Healthcare System, La Jolla, USA
      name:VA San Diego Healthcare System (116B), San Diego, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(373)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

4.87s.

LINK . SPRINGER . COM {}